This article contains affiliate links. We may earn a commission on qualifying purchases at no extra cost to you.

The Complete Peptide Stacking Guide: BPC-157 + TB-500 + GHK-Cu Protocols

Peptide stacking — using two or more peptides together in a coordinated protocol — has become one of the most discussed topics in the peptide therapy community. When done correctly, combining peptides that target different phases of healing can produce results that no single peptide achieves alone.

This guide covers the science behind stacking BPC-157, TB-500, and GHK-Cu, along with practical protocols, timing strategies, cycling schedules, and safety considerations for 2026.

Quick Answer

• BPC-157 + TB-500 is the most popular healing stack (often called the "Wolverine Protocol"), targeting inflammation reduction and tissue repair simultaneously
• Adding GHK-Cu creates a triple stack that covers all three phases of healing: inflammation, proliferation, and collagen remodeling
• Cycling is essential to prevent receptor desensitization — most protocols run 8-12 weeks on, followed by 4 weeks off, with some using 5-days-on, 2-days-off micro-cycles
• Each peptide in the stack works through different mechanisms, so combining them creates genuine synergy rather than redundancy

---

Why Stack Peptides? The Science of Synergy

Your body heals through a cascade of overlapping phases. No single peptide covers every stage. When you stack peptides that target different phases, you support the entire repair process from start to finish.

The three phases of tissue healing:

1. Inflammation phase (Days 0-7) — The body sends immune cells to the injury site, removes damaged tissue, and begins signaling for repair
2. Proliferation phase (Days 4-21) — New blood vessels form, fibroblasts lay down collagen, and new tissue fills the wound
3. Remodeling phase (Day 21 - 2 years) — Collagen reorganizes, tissue strengthens, and the repair site matures

A well-designed peptide stack maps individual peptides to each of these phases:

• TB-500 — Primary anti-inflammatory and cell migration agent (Phases 1-2)
• BPC-157 — Local angiogenesis, growth factor upregulation, and ongoing repair (Phases 2-3)
• GHK-Cu — Collagen synthesis, tissue remodeling, and maturation (Phase 3)

This is why stacking outperforms single-peptide protocols for complex injuries. You are not just doubling the dose of one mechanism — you are covering mechanisms that a single peptide cannot.

The Big Three: Individual Peptide Profiles

Before diving into stacking protocols, you need to understand what each peptide does on its own. For a deeper comparison of the first two, see our BPC-157 vs. TB-500 breakdown.

BPC-157 (Body Protection Compound-157)

What it is: A 15-amino-acid peptide derived from human gastric juice.

Primary mechanisms:

• Promotes angiogenesis (new blood vessel formation) at injury sites
• Upregulates growth factors including VEGF and EGF
• Modulates nitric oxide pathways for anti-inflammatory effects
• Accelerates tendon-to-bone healing in animal models
• Demonstrates gastroprotective effects when taken orally

Key research findings:

• Rat Achilles tendon transection models showed significantly improved biomechanical properties and collagen organization with BPC-157 treatment
• Stable in human gastric juice for over 24 hours — unusual among bioactive peptides
• No adverse effects or toxicities reported in preclinical studies across dozens of animal models

Typical standalone dose: 250-500 mcg subcutaneously, 1-2x daily

For a comprehensive overview, see our BPC-157 Complete Guide.

TB-500 (Thymosin Beta-4 Fragment)

What it is: A synthetic 43-amino-acid peptide fragment of thymosin beta-4, an endogenous protein upregulated in response to tissue injury.

Primary mechanisms:

• Sequesters G-actin monomers, maintaining a reservoir for rapid cytoskeletal assembly
• Promotes cell migration to injury sites
• Stimulates angiogenesis and new blood vessel formation
• Reduces inflammation through downregulation of pro-inflammatory cytokines
• Improves collagen alignment during tendon healing

Key research findings:

• Thymosin beta-4-treated wound sites showed accelerated closure in dermal wound models (Malinda et al., 1999)
• Tendon injury models demonstrate better collagen arrangement, enhanced tensile strength, and decreased pain markers
• Promotes cardiac repair in animal models of myocardial infarction

Typical standalone dose: 2-5 mg subcutaneously, 1-2x per week (note: weekly, not daily)

GHK-Cu (Copper Tripeptide)

What it is: A naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) bound to a copper ion, found in human plasma, saliva, and urine.

Primary mechanisms:

• Stimulates collagen synthesis — studies show up to 70% increase in collagen production in fibroblast cultures
• Activates metalloproteinases for tissue remodeling
• Promotes decorin synthesis for organized collagen architecture
• Attracts immune cells and fibroblasts to repair sites
• Antioxidant and anti-inflammatory properties

Key research findings:

• Reduced wrinkle volume by 55.8% and wrinkle depth by 32.8% compared to control in clinical skin studies
• Accelerated wound closure by 40-50% compared to untreated controls in animal models
• Upregulates over 4,000 genes related to tissue repair and regeneration (Pickart et al., 2015)
• Produces a 31.6% reduction in wrinkle volume compared to Matrixyl 3000 in head-to-head testing

Typical standalone dose: 1-2 mg subcutaneously, 1x daily or 200-600 mcg topically

For more on peptides in skincare applications, see What Do Peptides Do in Skincare?.

Stack #1: The Wolverine Protocol (BPC-157 + TB-500)

This is the most widely used peptide stack in the recovery and healing community. The name comes from the idea that combining these two peptides creates an accelerated healing response.

Why It Works

BPC-157 and TB-500 complement each other through distinct but overlapping mechanisms:

• TB-500 acts systemically — it circulates throughout the body and reduces inflammation broadly while promoting cell migration to damaged areas
• BPC-157 acts more locally — it concentrates at injury sites and stimulates angiogenesis and growth factor release at the point of damage

Together, TB-500 brings the repair cells to the area while BPC-157 creates the blood supply and chemical signals those cells need to rebuild tissue.

Wolverine Protocol Dosing

Standard protocol (moderate injury):

Peptide	Loading Phase (Weeks 1-2)	Maintenance Phase (Weeks 3-8)	Frequency
BPC-157	500 mcg	250 mcg	Daily (subQ)
TB-500	5 mg	2.5 mg	2x/week (subQ)

Aggressive protocol (significant injury, post-surgical):

Peptide	Loading Phase (Weeks 1-4)	Maintenance Phase (Weeks 5-12)	Frequency
BPC-157	500 mcg 2x/day	500 mcg 1x/day	Daily (subQ)
TB-500	5 mg	2.5 mg	2x/week (subQ)

Injection Timing and Location

• BPC-157: Inject subcutaneously as close to the injury site as practical. For a knee injury, inject into the fat pad around the knee. For gut healing, some practitioners recommend subcutaneous abdominal injection.
• TB-500: Inject subcutaneously in the abdomen or deltoid area. TB-500 is systemic, so injection location matters less than with BPC-157.
• Timing: Inject BPC-157 in the morning and/or evening. Inject TB-500 on non-consecutive days (e.g., Monday and Thursday).
• Separation: You can inject both peptides on the same day but use different injection sites.

Stack #2: The Triple Healing Stack (BPC-157 + TB-500 + GHK-Cu)

Adding GHK-Cu to the Wolverine Protocol creates a comprehensive stack that addresses all three healing phases. This combination is sometimes called the "GLOW" protocol in research circles (though specific product blends may vary).

Phase-by-Phase Coverage

Healing Phase	Primary Peptide	Supporting Peptide
Inflammation (Days 0-7)	TB-500	BPC-157
Proliferation (Days 4-21)	BPC-157	TB-500
Remodeling (Day 21+)	GHK-Cu	BPC-157

Triple Stack Dosing Protocol

8-week protocol:

Peptide	Weeks 1-2 (Loading)	Weeks 3-8 (Maintenance)	Frequency
BPC-157	500 mcg	250 mcg	Daily (subQ)
TB-500	5 mg	2.5 mg	2x/week (subQ)
GHK-Cu	2 mg	1 mg	Daily (subQ)

Ratio Considerations

Some research protocols and pre-mixed blends use a 5:1:1 ratio of GHK-Cu to TB-500 to BPC-157 by weight. This ratio reflects the higher dosing requirements of GHK-Cu relative to the other two peptides. However, when running individual peptides (not pre-mixed), most practitioners dose each peptide independently at its standard therapeutic range.

Best Candidates for the Triple Stack

The triple stack is best suited for:

• Chronic tendon injuries (tendinopathy, tennis elbow, Achilles issues)
• Post-surgical recovery (ACL reconstruction, rotator cuff repair)
• Complex musculoskeletal injuries involving multiple tissue types
• Athletes in recovery phases seeking to optimize tissue quality during healing
• Aging-related tissue degeneration where collagen remodeling is impaired

Stack #3: Recovery + Anti-Aging (BPC-157 + GHK-Cu)

This lighter stack is popular among users focused on general wellness, skin health, and longevity rather than acute injury recovery.

Why This Combination Works

• BPC-157 provides internal tissue support, gut healing, and anti-inflammatory effects
• GHK-Cu drives collagen remodeling, skin quality, and tissue regeneration

Without TB-500, this stack is less aggressive for acute injuries but offers excellent support for chronic conditions and general anti-aging protocols.

BPC-157 + GHK-Cu Protocol

Peptide	Daily Dose	Frequency	Duration
BPC-157	250 mcg	Daily (subQ or oral)	8-12 weeks
GHK-Cu	1-2 mg subQ or 200-600 mcg topical	Daily	8-12 weeks

For those interested in topical applications of GHK-Cu, check out our guide on Best Peptide Serums for Skin 2026.

Stack #4: Growth Hormone Secretagogue Stacks

While the healing stacks above focus on tissue repair, many people stack peptides for growth hormone (GH) optimization. Common GH secretagogue stacks include combinations like:

• CJC-1295 + Ipamorelin — the most popular GH stack, combining a GHRH analog with a ghrelin mimetic
• GHRP-6 + CJC-1295 — stronger GH pulse but with increased appetite
• Tesamorelin + Ipamorelin — FDA-approved tesamorelin paired with ipamorelin

These stacks work differently from healing peptides. GH secretagogues stimulate the pituitary gland to release more growth hormone, which indirectly supports tissue repair, fat metabolism, and muscle growth.

Important cycling note: GH secretagogue stacks require more careful cycling than healing peptides. Hexarelin, for example, should be limited to 4-8 weeks maximum due to rapid receptor desensitization. CJC-1295/Ipamorelin combinations are typically run for 12-16 weeks on, 4-6 weeks off.

For a broader look at how peptide therapy compares to hormone replacement, see Peptide Therapy vs. HRT.

Cycling Protocols: How to Prevent Tolerance

Cycling — alternating periods of peptide use with breaks — is essential for maintaining effectiveness and preventing receptor desensitization. Without cycling, your body can downregulate the receptors that peptides bind to, reducing their effects over time.

Micro-Cycling: 5 Days On, 2 Days Off

The most common micro-cycling approach involves taking peptides for 5 consecutive days, then taking 2 days off (typically weekends). This brief pause helps maintain receptor sensitivity without significantly interrupting the healing process.

Pros:

• Simple to follow
• Provides consistent therapeutic benefit
• Sufficient receptor recovery for most healing peptides
• Easy to track (weekday/weekend schedule)

Cons:

• May not be sufficient for peptides with strong receptor desensitization (e.g., hexarelin)
• Some interruption of healing continuity

Macro-Cycling: Weeks On, Weeks Off

For longer protocols, macro-cycling involves running peptides for a set number of weeks, then taking a complete break:

Protocol Type	On Period	Off Period	Best For
Short cycle	4-6 weeks	2-3 weeks	Acute injuries, GH secretagogues
Standard cycle	8-12 weeks	4 weeks	Most healing protocols
Extended cycle	12-16 weeks	4-6 weeks	Chronic conditions, GH stacks

Cycling Healing Peptides vs. GH Secretagogues

Healing peptides (BPC-157, TB-500, GHK-Cu) are generally used in finite healing blocks — you run them until the injury is healed, then stop. They do not require the same strict on/off cycling as endocrine peptides because they work through growth factor and repair pathways rather than hormone receptors.

GH secretagogues (CJC-1295, Ipamorelin, GHRP-6, Hexarelin) work through the endocrine system and can cause meaningful receptor downregulation. These require more disciplined cycling schedules.

Key rule: Always take at least 15 days off between cycles to prevent receptor desensitization, regardless of which peptides you are stacking.

Off-Cycle Protocol

During your off-cycle period:

• Stop all peptides in the stack — do not substitute one for another
• Continue basic supplements (vitamins, minerals, protein) to support ongoing recovery
• Monitor recovery progress — take notes on pain levels, mobility, and function
• Do not introduce new peptides during the off period
• Resume only if needed — if the injury has healed, you may not need another cycle

Timing and Administration Tips

Getting the timing right can influence how well your stack works. Here are practical guidelines:

Daily Timing Schedule

Morning (fasted):

• BPC-157: 250-500 mcg subcutaneous injection
• GHK-Cu: 1-2 mg subcutaneous injection (if using injectable)
• Wait 20-30 minutes before eating

Evening (before bed, 2+ hours after last meal):

• BPC-157: 250 mcg (if splitting dose)
• TB-500: 2.5-5 mg (on scheduled injection days — e.g., Monday and Thursday evenings)

Can You Mix Peptides in the Same Syringe?

This is a common question, and the answer depends on the specific peptides:

• BPC-157 + TB-500: Can be mixed in the same syringe. Many practitioners do this to reduce injection frequency. However, some prefer separate injections to maintain precise dosing.
• GHK-Cu + other peptides: GHK-Cu contains copper ions that may interact with other peptides. It is generally recommended to inject GHK-Cu separately or at a different site.
• Pre-mixed blends: Several vendors sell pre-mixed "GLOW" or "Wolverine" blends that combine these peptides in a single vial. These are convenient but offer less dosing flexibility.

Food and Supplement Interactions

• Inject on an empty stomach — food can slow absorption and interfere with peptide signaling
• Avoid antacids before oral BPC-157 — the arginine salt is designed to survive stomach acid, and antacids may paradoxically reduce absorption by altering pH beyond the optimal range
• Zinc and copper balance — if taking GHK-Cu, be aware of copper intake from other supplements. Excessive copper without adequate zinc can cause imbalances
• Collagen supplements may complement GHK-Cu by providing raw materials for the collagen synthesis it stimulates

Advanced Stacking Strategies

Phased Stacking: Sequential Introduction

Rather than starting all peptides simultaneously, phased stacking introduces each peptide at the stage of healing where it has the most impact. This approach has several advantages:

• Easier to identify side effects — if a reaction occurs, you know which peptide caused it
• Optimized timing — each peptide enters the protocol when its mechanism is most needed
• Lower initial cost — you only purchase the next peptide when you are ready for it

Example phased protocol for a moderate tendon injury:

Week	Peptides Active	Rationale
1-2	TB-500 only	Reduce inflammation, promote cell migration
3-4	TB-500 + BPC-157	Add local repair while maintaining anti-inflammatory support
5-8	BPC-157 + GHK-Cu	Transition to repair and remodeling phase
9-10	GHK-Cu only	Focus on collagen maturation and tissue quality
11-14	Off cycle	Allow receptor resensitization

Pulsed Dosing Within a Stack

Some practitioners use pulsed dosing — varying the dose of individual peptides within a stack based on where they are in the healing timeline. For example:

• BPC-157 pulse: Start at 500 mcg/day for weeks 1-3, reduce to 250 mcg/day for weeks 4-8
• TB-500 pulse: Start at 5 mg 2x/week for weeks 1-2, reduce to 2.5 mg 2x/week for weeks 3-6
• GHK-Cu steady state: Maintain 1 mg/day throughout the protocol

The "front-loading" approach delivers higher concentrations during the most critical early healing phase, then reduces to maintenance levels as tissue repair progresses.

Oral + Injectable Hybrid Stacks

Not every peptide in a stack needs to be injected. A practical hybrid approach:

• BPC-157: Oral (arginine salt capsules, 500-1000 mcg/day) — convenient daily dosing without needles
• TB-500: Injectable (2.5 mg subcutaneous, 2x/week) — requires injection due to poor oral bioavailability
• GHK-Cu: Topical (200-600 mcg in cream form, applied to injury site) — non-invasive delivery for skin and superficial tissue

This reduces the number of daily injections from 2-3 to just 2 per week while maintaining coverage across all healing phases.

Stacking with Lifestyle Interventions

Peptides do not work in isolation. Their effectiveness is amplified — or undermined — by lifestyle factors:

• Sleep: Growth hormone release peaks during deep sleep. Both BPC-157 and GH secretagogue stacks benefit from 7-9 hours of quality sleep. Consider taking evening peptide doses 30-60 minutes before bed.
• Nutrition: Adequate protein intake (1.0-1.6 g/kg body weight) provides the amino acid building blocks that peptides signal the body to assemble. collagen peptides (dietary, not therapeutic) may complement GHK-Cu by providing raw materials.
• Movement: Light activity and prescribed physical therapy exercises increase blood flow to injury sites, enhancing peptide delivery. Avoid high-intensity exercise during acute healing phases.
• Hydration: Adequate water intake supports overall cellular function and may improve peptide absorption and distribution.

Safety Considerations for Stacking

Stacking multiple peptides increases the complexity of your protocol and introduces additional safety considerations.

Known Interactions

• BPC-157 + TB-500: No known negative interactions. These are the most commonly combined peptides with extensive anecdotal safety data.
• GHK-Cu + BPC-157/TB-500: No reported adverse interactions. The copper in GHK-Cu is at physiological levels and does not pose toxicity concerns at standard doses.
• Healing peptides + GH secretagogues: Can be used together, but adds endocrine complexity. Monitor for signs of GH excess (joint swelling, water retention, carpal tunnel symptoms).

Red Flags to Watch For

Stop your protocol and consult a healthcare provider if you experience:

• Persistent swelling at injection sites that does not resolve within 48 hours
• Signs of infection (redness, warmth, pus) at injection sites
• Unusual fatigue or malaise that worsens over the protocol
• Joint pain or swelling not related to your existing injury
• Numbness or tingling in extremities
• Significant changes in appetite, sleep, or mood

Who Should NOT Stack Peptides

• Pregnant or breastfeeding women — insufficient safety data
• People with active cancer — angiogenesis-promoting peptides (BPC-157, TB-500) could theoretically support tumor blood supply
• Those on blood thinners — some peptides affect clotting pathways
• People with copper metabolism disorders (Wilson's disease) — avoid GHK-Cu
• Anyone under 18 — no pediatric safety data exists

Building Your First Stack: Step-by-Step

If you are new to peptide stacking, here is a sensible approach:

Step 1: Start with a Single Peptide

Before stacking, run a single peptide for 2-4 weeks to establish your baseline response and rule out individual reactions. BPC-157 at 250 mcg daily is the most common starting point. Our How to Start Peptide Therapy guide covers everything you need to know.

Step 2: Add One Peptide at a Time

After 2-4 weeks on BPC-157 alone, add TB-500 at 2.5 mg twice weekly. Run this dual stack for another 2-4 weeks before considering adding GHK-Cu.

Step 3: Establish Your Protocol

Once you have confirmed tolerability of each peptide individually, you can run the full stack. Choose a protocol length (8-12 weeks) and commit to consistent dosing.

Step 4: Track Everything

Keep a simple log of:

• Daily doses and injection sites
• Pain levels (1-10 scale)
• Range of motion or functional measures
• Sleep quality
• Energy levels
• Any side effects

Step 5: Cycle Off and Assess

After your protocol ends, take a full 4-week break. Assess your progress and decide whether another cycle is needed.

Cost Estimates for Common Stacks

Peptide stacking adds up. Here is what to budget for the most popular combinations:

Wolverine Protocol (BPC-157 + TB-500) — 8 Weeks

Item	Cost	Notes
BPC-157 10mg x 2 vials	$110-160	At 250mcg/day = ~80 days
TB-500 5mg x 4 vials	$200-320	At 2.5mg 2x/week = ~8 weeks
Bacteriostatic water x 2	$16-30
Syringes + alcohol swabs	$15-25
Total 8-week cost	$341-535

Triple Stack (BPC-157 + TB-500 + GHK-Cu) — 8 Weeks

Item	Cost	Notes
BPC-157 10mg x 2 vials	$110-160
TB-500 5mg x 4 vials	$200-320
GHK-Cu 50mg vial	$40-70	At 1mg/day = ~50 days
Bacteriostatic water x 3	$24-45
Syringes + alcohol swabs	$20-30
Total 8-week cost	$394-625

For trusted supplement options that don't require injection, see our Best Peptide Supplements 2026 roundup.

Is Stacking Worth the Extra Cost?

The decision to stack comes down to a cost-benefit calculation specific to your situation. Here are scenarios where stacking clearly provides value over single-peptide use:

• Significant injuries with multiple tissue types involved (e.g., a torn ligament affecting the surrounding tendons and joint capsule)
• Post-surgical recovery where maximizing healing speed has measurable quality-of-life benefits
• Chronic conditions that have not responded to single-peptide protocols after a full cycle
• Athletes or active professionals whose livelihood depends on rapid return to function

Conversely, stacking may not be necessary if:

• Your injury is mild and responding well to a single peptide
• Budget constraints make a multi-peptide protocol unsustainable for the full cycle length
• You are using peptides for general wellness rather than injury recovery
• You are new to peptides and have not yet established your response to individual compounds

Frequently Asked Questions

Q: Can I stack more than three peptides at once?

You can, but it is generally not recommended for most people. Each additional peptide adds complexity, cost, and variables that make it harder to determine what is working. Most practitioners suggest limiting stacks to 2-3 peptides for healing goals. If you add GH secretagogues or other functional peptides, the total may reach 4-5, but this should be done under clinical supervision.

Q: Do I need to inject all stacked peptides, or can some be taken orally?

BPC-157 is available in effective oral formulations (arginine salt capsules) and can be used orally within a stack while injecting TB-500 and GHK-Cu. TB-500 and GHK-Cu are most effective when injected subcutaneously, as their oral bioavailability is very low. A mixed-route stack (oral BPC-157 + injectable TB-500) is a practical option for people who want to minimize injections.

Q: How long should I wait between stacking cycles?

A minimum of 4 weeks off between full stacking cycles is recommended. During the off period, stop all peptides to allow receptor resensitization. Some practitioners extend the break to 6-8 weeks after longer or more aggressive protocols. The goal is to restore full receptor sensitivity so your next cycle is as effective as the first.

Q: Is it safe to stack peptides with prescription medications?

This depends entirely on the medications. Peptides that promote angiogenesis (BPC-157, TB-500) may theoretically interact with blood thinners or medications that affect blood vessel growth. GH secretagogues can interact with diabetes medications by affecting insulin sensitivity. Always disclose peptide use to your healthcare provider, especially if you take prescription medications.

Q: Can women use the same stacking protocols as men?

Yes. The healing peptides covered in this guide (BPC-157, TB-500, GHK-Cu) do not have gender-specific dosing differences in the existing research. Both men and women use the same dose ranges. However, women who are pregnant, planning pregnancy, or breastfeeding should avoid all peptide protocols due to insufficient safety data.

---

Medical Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. BPC-157, TB-500, and GHK-Cu are not FDA-approved for human therapeutic use. The information presented is based on preclinical research, primarily animal studies, and limited human data. Always consult a qualified healthcare provider before starting any peptide protocol. Self-administration of peptides carries inherent risks including infection, incorrect dosing, and unknown drug interactions.

-- The Peptide Front Team